Australians suffering sleep apnoea are set to benefit from the opening of a new facility in Melbourne today which will produce new anti-snoring devices that are customised to an individual’s specific needs using 3D printing technology.
The ‘O2Vent’ stops patients from snoring by delivering air to the back of the mouth, alleviating multiple sites of obstruction including the nose, soft palate and tongue.
This revolutionary personalised lightweight titanium device could benefit the estimated one million Australians that suffer from sleep apnoea.
The opening today of the Oventus 3D printing facility at CSIRO’s Clayton site is a great example of Australian research and technology being rolled out for the benefit of Australians.
The facility will manufacture these important O2Vent devices that have the potential to change the lives of millions of people around the world with sleep-disordered breathing.
Sleep apnoea is caused by excessive snoring, which can lead to high blood pressure, stroke, irregular heartbeats, heart attacks and diabetes.
The partnership between Oventus and CSIRO is an example of collaboration between private sector and public research, creating businesses opportunities and new jobs – a key aim of the National Innovation and Science Agenda.
Oventus recently listed on the ASX following a successful IPO that raised $12 million, and they are set to launch onto the US market in early 2017, where over 37 million people regularly suffer from snoring.
This week marks one year since the Turnbull Government launched the National Innovation Science Agenda – and major initiatives are already underway to boost investment, generate jobs and improve the quality of our lives.
More information on the O2Vent device is available online at: http://www.oventus.com.au